succinimidyl 4-(p-maleimidophenyl)butyrate

Names

[ Name ]:
succinimidyl 4-(p-maleimidophenyl)butyrate

[Synonym ]:
MFCD00054961
succinimidyl 4-(p-maleimidophenyl)butyrate
N-Succinimidyl 4-(4-maleimidophenyl)butyrate
1-(4-{4-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl}phenyl)-1H-pyrrole-2,5-dione
1H-Pyrrole-2,5-dione, 1-(4-(4-((2,5-dioxo-1-pyrrolidinyl)oxy)-4-oxobutyl)phenyl)-
1H-Pyrrole-2,5-dione, 1-[4-[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl]phenyl]-

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
551.1±60.0 °C at 760 mmHg

[ Melting Point ]:
130-131ºC

[ Molecular Formula ]:
C₁₈H₁₆N₂O₆

[ Molecular Weight ]:
356.329

[ Flash Point ]:
287.1±32.9 °C

[ Exact Mass ]:
356.100830

[ PSA ]:
101.06000

[ LogP ]:
-0.31

[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C

[ Index of Refraction ]:
1.637

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
26-36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis.

Nat. Commun. 5 , 4478, (2014)

Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surge...

AFM imaging of immobilized fibronectin: does the surface conjugation scheme affect the protein orientation/conformation?

Langmuir 23(19) , 9745-51, (2007)

Covalent grafting of biomolecules could potentially improve the biocompatibility of materials. However, these molecules have to be grafted in an active conformation to play their biological roles. The...

Herceptin-conjugated temperature-sensitive immunoliposomes encapsulating gemcitabine for breast cancer.

Arch. Pharm. Res. 39 , 350-8, (2016)

Gemcitabine (2',2'-difluorodeoxycytidine, GCT) is an analog of deoxycytidine with cytotoxicity for breast cancer cells. However, because of its hepatotoxicity and other side effects, an efficient drug...